March 1, 2013 BEST IN CLASS OR BUY THE CLASS II After the last MTSL Issue (#748) titled âThe New Hot Classesâ â âsuper pillsâ for hepatitis C, and small molecule inhibitors of the novel targets BTK, Pi3K, JAK and PCSK9 â the ideal sequel to that subject is âBest In Class or Buy The[…]
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.